PT1004592E - Novos derivados da eritromicina seu processo de preparacao e sua aplicacao como medicamentos - Google Patents

Novos derivados da eritromicina seu processo de preparacao e sua aplicacao como medicamentos

Info

Publication number
PT1004592E
PT1004592E PT99402907T PT99402907T PT1004592E PT 1004592 E PT1004592 E PT 1004592E PT 99402907 T PT99402907 T PT 99402907T PT 99402907 T PT99402907 T PT 99402907T PT 1004592 E PT1004592 E PT 1004592E
Authority
PT
Portugal
Prior art keywords
erythromycine
medicines
application
preparation process
new derivatives
Prior art date
Application number
PT99402907T
Other languages
English (en)
Portuguese (pt)
Inventor
Alexis Denis
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of PT1004592E publication Critical patent/PT1004592E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PT99402907T 1998-11-24 1999-11-23 Novos derivados da eritromicina seu processo de preparacao e sua aplicacao como medicamentos PT1004592E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9814782A FR2786188B1 (fr) 1998-11-24 1998-11-24 Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments

Publications (1)

Publication Number Publication Date
PT1004592E true PT1004592E (pt) 2003-12-31

Family

ID=9533122

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99402907T PT1004592E (pt) 1998-11-24 1999-11-23 Novos derivados da eritromicina seu processo de preparacao e sua aplicacao como medicamentos

Country Status (24)

Country Link
US (2) US6440941B1 (enExample)
EP (1) EP1004592B1 (enExample)
JP (1) JP2000159790A (enExample)
KR (1) KR100587445B1 (enExample)
CN (1) CN1165546C (enExample)
AR (1) AR021388A1 (enExample)
AT (1) ATE245160T1 (enExample)
AU (1) AU772171B2 (enExample)
BR (1) BR9905735A (enExample)
CA (1) CA2290136C (enExample)
DE (1) DE69909577T2 (enExample)
DK (1) DK1004592T3 (enExample)
ES (1) ES2198867T3 (enExample)
FR (1) FR2786188B1 (enExample)
HU (1) HUP9904392A3 (enExample)
IL (1) IL133101A (enExample)
MX (1) MXPA99010813A (enExample)
NO (1) NO314729B1 (enExample)
PL (1) PL336736A1 (enExample)
PT (1) PT1004592E (enExample)
RU (1) RU2237672C2 (enExample)
TR (1) TR199902888A3 (enExample)
TW (1) TWI247747B (enExample)
ZA (1) ZA997176B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
CZ20012675A3 (cs) 1999-01-27 2002-04-17 Pfizer Products Inc. Ketolidová antibiotika
BR0010938A (pt) 1999-05-24 2002-03-19 Pfizer Prod Inc Derivados da 13-metil eritromicina
ES2222966T3 (es) 2000-06-30 2005-02-16 Pfizer Products Inc. Macrolidos antibioticos.
US7601695B2 (en) * 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
FR2862647B1 (fr) 2003-11-25 2008-07-04 Aventis Pharma Sa Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant
JP2008508322A (ja) * 2004-07-28 2008-03-21 ランバクシー ラボラトリーズ リミテッド 抗菌剤としてのケトライド誘導体
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
US8552162B2 (en) * 2008-05-09 2013-10-08 Enanta Pharmaceuticals, Inc. Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivatives
CN102245195B (zh) * 2008-10-24 2016-01-13 森普拉制药公司 使用含三唑的大环内酯的生物防御
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ,インコーポレイテッド マラリア、結核、及びmac病の治療方法
EP3009442B1 (en) 2010-03-22 2019-06-19 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
CA2799937A1 (en) 2010-05-20 2011-11-24 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
WO2012034058A1 (en) * 2010-09-10 2012-03-15 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
EP2630133A1 (de) 2010-10-22 2013-08-28 Bayer Intellectual Property GmbH Neue heterocylische verbindungen als schädlingsbekämpfungsmittel
CA2868262A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
HK1217665A1 (zh) 2013-03-14 2017-01-20 森普拉制药公司 用於治療呼吸道疾病的方法及其製劑
HK1218864A1 (zh) 2013-03-15 2017-03-17 森普拉制药公司 用於制备大环内酯抗菌剂的收敛方法
CN106432383A (zh) * 2016-09-14 2017-02-22 重庆两江药物研发中心有限公司 索利霉素及其中间体的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182895A (en) * 1976-12-20 1980-01-08 Sterling Drug Inc. 1-Amino-lower-alkyl-3,4-diphenyl-1H-pyrazoles
CA1098527A (en) * 1976-12-20 1981-03-31 Denis M. Bailey 1-amino-lower-alkyl-3,4-diphenyl-1h-pyrazoles
JPH04234891A (ja) * 1990-03-05 1992-08-24 Fujisawa Pharmaceut Co Ltd 新規セフェム化合物およびその塩
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
CN1259135A (zh) * 1997-06-11 2000-07-05 辉瑞产品公司 9-肟红霉素衍生物
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments

Also Published As

Publication number Publication date
NO995745L (no) 2000-05-25
AR021388A1 (es) 2002-07-17
IL133101A (en) 2007-02-11
ZA997176B (en) 2000-11-20
DK1004592T3 (da) 2003-10-27
TWI247747B (en) 2006-01-21
RU2237672C2 (ru) 2004-10-10
AU5952299A (en) 2000-05-25
CA2290136C (fr) 2010-07-20
US6440941B1 (en) 2002-08-27
FR2786188A1 (fr) 2000-05-26
ATE245160T1 (de) 2003-08-15
TR199902888A2 (xx) 2000-06-21
NO314729B1 (no) 2003-05-12
TR199902888A3 (tr) 2000-06-21
BR9905735A (pt) 2000-08-08
AU772171B2 (en) 2004-04-08
CN1165546C (zh) 2004-09-08
US6664398B2 (en) 2003-12-16
KR20000057017A (ko) 2000-09-15
CN1263101A (zh) 2000-08-16
ES2198867T3 (es) 2004-02-01
FR2786188B1 (fr) 2002-10-31
NO995745D0 (no) 1999-11-23
DE69909577T2 (de) 2004-06-03
HUP9904392A3 (en) 2001-08-28
PL336736A1 (en) 2000-06-05
JP2000159790A (ja) 2000-06-13
EP1004592B1 (fr) 2003-07-16
EP1004592A1 (fr) 2000-05-31
HUP9904392A2 (hu) 2000-05-28
DE69909577D1 (de) 2003-08-21
MXPA99010813A (es) 2005-09-08
CA2290136A1 (fr) 2000-05-24
IL133101A0 (en) 2001-03-19
KR100587445B1 (ko) 2006-06-08
HU9904392D0 (en) 2000-01-28
US20030050254A1 (en) 2003-03-13

Similar Documents

Publication Publication Date Title
PT676409E (pt) Novos derivados da eritromicina seu processo de preparacao e sua aplicacao como medicamentos
PT1004592E (pt) Novos derivados da eritromicina seu processo de preparacao e sua aplicacao como medicamentos
BR9707709A (pt) Derivados da eritromicina seu processo de preparação e sua aplicação como medicamentos
PT1119557E (pt) Derivados de indeno- nafto- e benzociclohepta-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorecticos
PT1016669E (pt) Novos derivados da eritromicina, seu processo de preparacao e a sua aplicacao como medicamentos
PT1006110E (pt) Derivados de acil-piperazinil-pirimidinas sua preparacao e aplicacao como medicamentos
PT1083171E (pt) Derivados de pirazolina sua preparacao e aplicacao como medicamentos
BR9404114A (pt) Composição farmacêutica e seu processo de preparação
BR9610503A (pt) Novos derivados da 5-o-desosaminil 6-o-metil eritronolida a seu processo de preparação e sua aplicação para a preparação de produtos biologicamente ativos
BR9611198A (pt) Composto processo de preparação do mesmo e composição farmacêutica
BR9609420A (pt) Derivados de 4-fenilaminotiazol seu processo de preparação e as composições farmacêuticas contendo os mesmos
ATE246490T1 (de) Pharmazeutische zusammensetzung von topiramate
BR9507700A (pt) Novos derivados da eritromicida proceso de preparação dos mesmos e aplicação dos mesmos como medicamentos
BR9400475A (pt) Processo de preparação de zeólita modificada e zeólita modificada
LV12624A (lv) Thienylazolylalcoxyethanamines their preparation and their application as medicaments
BR9408425A (pt) Sílica, seu processo de preparação utilização da sílica e composição dentifrícia
PT1230230E (pt) Derivados de indeno-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorexigenico
BR9002736A (pt) Curral dobravel aperfeicoado e seu processo de montagem
BR9507931A (pt) Composição de alvejamento aquosa e processo de preparação da mesma
PT946566E (pt) Formas pro-farmacos e analogos da camptotecina sua aplicacao como medicamentos
BR9506020A (pt) Composição aquosa e processo de preparaçao da mesma
BR9610959A (pt) Novos derivados da 5-0-desosaminil 6-0-metil eritronolida a seu processo de preparo e sua aplicação ao preparo e sua aplicação ao preparo de produtos biologicamente ativos
BRPI0208998A2 (pt) formulação farmacêutica com gosto dissumulado e seu processo de preparo
BR9611573A (pt) Processo de preparação de derivados de fenilimidazolidina
PT931088E (pt) Novos derivados da eritromicina seu processo de preparacao e sua aplicacao como medicamentos